NATHAN G ADAMS, DMD, MD
Medical Practice at 1100, Salt Lake City, UT
License number
Utah 54019
Category
Medical Practice
Type
Oral & Maxillofacial Surgery
License number
Utah D12304
Category
Medical Practice
Type
Oral & Maxillofacial Surgery
License number
Utah 7961990-9924
Category
Medical Practice
Type
Oral & Maxillofacial Surgery
License number
Utah 7961990-1205
Category
Medical Practice
Type
Oral & Maxillofacial Surgery
Address
Address
3920 S 1100 E STE 150, Salt Lake City, UT 84124
Phone
(801) 262-7447
(801) 262-7450 (Fax)
(801) 262-7450 (Fax)
Personal information
See more information about NATHAN G ADAMS at radaris.comName
Address
Phone
4769 W Arno Way, West Jordan, UT 84084
455 N 900 E, Lehi, UT 84043
35 W 200 N, Washington, UT 84780
909 N 4000 W, Clearfield, UT 84015
1357 400 E, Logan, UT 84341
Professional information
Dr. Nathan G Adams, Mankato MN - MD (Doctor of Medicine)
Specialties:
General Surgery
Age:
46
Address:
ASSOCIATES IN ORAL MAX FACIAL SURGERY
1990 Premier Dr, Mankato 56001
(507) 625-9330 (Phone), (507) 625-1440 (Fax)
KARL E LIND DDS A PROFESSIONAL CORPORATION
3920 S 1100 E SUITE 150, Salt Lake City 84124
(801) 262-7447 (Phone), (801) 262-7447 (Fax)
1990 Premier Dr, Mankato 56001
(507) 625-9330 (Phone), (507) 625-1440 (Fax)
KARL E LIND DDS A PROFESSIONAL CORPORATION
3920 S 1100 E SUITE 150, Salt Lake City 84124
(801) 262-7447 (Phone), (801) 262-7447 (Fax)
Procedures:
Incisional/Ventral Hernia Repair, Open
Conditions:
Incisional Hernia
Languages:
English
Education:
Medical School
Mayo Medical School
Graduated: 2010
Mayo Medical School
Graduated: 2010
Accountant At Flying J
Position:
accountant at flying j
Location:
Greater Salt Lake City Area
Industry:
Accounting
Work:
flying j
-
accountant
Estrenes For Inducting Hypothalamic Effects
US Patent:
6352980, Mar 5, 2002
Filed:
Sep 21, 1999
Appl. No.:
09/399977
Inventors:
David L. Berliner - Atherton CA
Nathan W. Adams - Salt Lake City UT
Clive L. Jennings-White - Salt Lake City UT
Nathan W. Adams - Salt Lake City UT
Clive L. Jennings-White - Salt Lake City UT
Assignee:
Pherin Pharmaceuticals, Inc. - Mountain View CA
International Classification:
A61K 3156
US Classification:
514169, 514170, 514177, 514178, 514182
Abstract:
The invention relates to estrene steroids, which bind to neuroepithelial receptors. The steroid is preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers.
Nathan G Adams, Salt Lake City UT
Specialties:
Oral Surgeon
Address:
3920 S 1100 E, Salt Lake City, UT 84124
Pregnane Steroids As Neurochemical Initiators Of Change In Human Hypothalamic Function And Related Pharmaceutical Compositions And Methods
US Patent:
5563131, Oct 8, 1996
Filed:
Aug 4, 1994
Appl. No.:
8/286073
Inventors:
David L. Berliner - Atherton CA
Clive L. Jennings-White - Salt Lake City UT
Nathan W. Adams - Salt Lake City UT
Clive L. Jennings-White - Salt Lake City UT
Nathan W. Adams - Salt Lake City UT
Assignee:
Pherin Corporation - Menlo Park CA
International Classification:
A61K 3156
US Classification:
514177
Abstract:
The invention relates to a method of altering hypothalamic function in an individual. The method comprises nasally administering a human vomeropherin, e. g. a pregnane steroid, or a pharmaceutical composition containing a vomeropherin, such that the vomeropherin binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers. Other embodiments of the invention include pharmaceutical compositions containing the steroids.
Androstane Steroids As Neurochemical Initiators Of Change In Human Hypothalamic Function And Related Pharmaceutical Compositions And Methods
US Patent:
2002014, Oct 3, 2002
Filed:
Aug 3, 2001
Appl. No.:
09/922216
Inventors:
David Berliner - Atherton CA, US
Nathan Adams - Salt Lake City UT, US
Clive Jennings-White - Salt Lake City UT, US
Nathan Adams - Salt Lake City UT, US
Clive Jennings-White - Salt Lake City UT, US
International Classification:
A61K031/56
US Classification:
514/182000, 514/179000
Abstract:
The invention relates to a method of altering hypothalamic function in an individual. The method comprises nasally administering a human semiochemical, e.g. an Androstane steroid, or a pharmaceutical composition containing a semiochemical, such that the ligand semiochemical binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers. Other embodiments of the invention include pharmaceutical compositions containing the steroids.
Method Of Altering Hypothalamic Function By Nasal Administration Of Estrene Steroids
US Patent:
5783571, Jul 21, 1998
Filed:
Sep 28, 1993
Appl. No.:
8/127980
Inventors:
David L. Berliner - Atherton CA
Nathan William Adams - Salt Lake City UT
Clive L. Jennings-White - Salt Lake City UT
Nathan William Adams - Salt Lake City UT
Clive L. Jennings-White - Salt Lake City UT
Assignee:
Pherin Corporation - Menlo Park CA
International Classification:
A61K 3156
US Classification:
514177
Abstract:
The invention relates to a method of altering hypothalamic function in an individual. The method comprises nasally administering a human semiochemical, e. g. an Estrene steroid, or a pharmaceutical composition containing an Estrene steroid, such that the ligand semiochemical binds to a specific neuroepithelial receptor. The steroid is preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers. Other embodiments of the invention include pharmaceutical compositions containing the steroids.
Steroids As Neurochemical Initiators Of Change In Human Blood Levels Of Lh
US Patent:
6066627, May 23, 2000
Filed:
Mar 29, 1996
Appl. No.:
8/625268
Inventors:
Clive L. Jennings-White - Salt Lake City UT
David L. Berliner - Atherton CA
Nathan W. Adams - Salt Lake City UT
David L. Berliner - Atherton CA
Nathan W. Adams - Salt Lake City UT
Assignee:
Pherin Corporation - Menlo Park CA
International Classification:
A61K 3156
US Classification:
514177
Abstract:
The invention relates to a method of altering the blood levels of LH or FSH in an individual. The method comprises nasally administering a steroid which is a human vomeropherin, such that the vomeropherin binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers.
Estrenes For Inducing Hypothalamic Effects
US Patent:
5925774, Jul 20, 1999
Filed:
Jun 1, 1995
Appl. No.:
8/460133
Inventors:
David L. Berliner - Atherton CA
Nathan W. Adams - Salt Lake City UT
Clive L. Jennings-White - Salt Lake City UT
Nathan W. Adams - Salt Lake City UT
Clive L. Jennings-White - Salt Lake City UT
Assignee:
Pherin Corporation - Menlo Park CA
International Classification:
C07J 300
US Classification:
552611
Abstract:
The invention relates to estrene steroids, which bind to neuroepithelial receptors. The steroid is preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers.
Novel Androstanes For Inducing Hypothalamic Effects
US Patent:
2002010, Aug 1, 2002
Filed:
Mar 9, 2001
Appl. No.:
09/803378
Inventors:
David Berliner - Atherton CA, US
Nathan Adams - Salt Lake City UT, US
Clive Jennings-White - Salt Lake City UT, US
Nathan Adams - Salt Lake City UT, US
Clive Jennings-White - Salt Lake City UT, US
International Classification:
C07J013/00, C07J003/00
US Classification:
552/530000, 552/610000, 552/611000
Abstract:
The invention relates to novel, androstane steroids which are the ligand semiochemicals which bind to neuroepithelial receptors.